Interleukin-2 in the treatment of hematologic malignancies

被引：0
|
作者：
Fefer, A
机构：
[1] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
CANCER JOURNAL | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S31 / S32
页数：2
相关论文
共 50 条
  • [21] INTERLEUKIN-2 AND THE TREATMENT OF LEUKEMIA AND LYMPHOMA
    BRENNER, MK
    LEUKEMIA & LYMPHOMA, 1991, 5 (2-3) : 77 - 83
  • [22] NEPHROTOXICITY OF INTERLEUKIN-2 TREATMENT IN CHILDREN
    COCHAT, P
    BRUNET, J
    PHILIP, T
    FLORET, D
    DAVID, L
    THERAPIE, 1988, 43 (02): : 131 - 131
  • [23] TREATMENT OF METASTATIC MELANOMA WITH INTERLEUKIN-2
    CHOSIDOW, O
    GUILLAUME, JC
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1992, 119 (01): : 65 - 73
  • [24] Interleukin-2 (IL-2) post high dose chemotherapy mobilized autologous stem cell transplant (ASCT) for hematologic malignancies.
    Oliveira, JSR
    Cecyn, KZ
    Parisio, K
    Faria, JR
    Ribeiro, MSS
    Chauffaille, MDLF
    Raineri, G
    BLOOD, 2001, 98 (11) : 396B - 397B
  • [25] INTERLEUKIN-2 AND THE INTERLEUKIN-2 RECEPTOR COMPLEX
    GAULTON, GN
    WILLIAMSON, P
    LYMPHOCYTE ACTIVATION, 1994, 59 : 91 - 114
  • [26] CORTICOSTEROID INTERLEUKIN-2 INTERACTIONS - INHIBITION OF BINDING OF INTERLEUKIN-2 TO INTERLEUKIN-2 RECEPTORS
    HORST, HJ
    FLAD, HD
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1987, 68 (01): : 156 - 161
  • [27] Topotecan in the treatment of hematologic malignancies
    Beran, M
    Kantarjian, H
    SEMINARS IN HEMATOLOGY, 1998, 35 (03) : 26 - 31
  • [28] Immunotoxins in the treatment of hematologic malignancies
    Kreitman, Robert J.
    Pastan, Ira
    CURRENT DRUG TARGETS, 2006, 7 (10) : 1301 - 1311
  • [29] The treatment of hematologic malignancies in pregnancy
    Vandenbriele, C.
    Dierickx, D.
    Amant, F.
    Delforge, M.
    FACTS VIEWS AND VISION IN OBGYN, 2010, 2 (02): : 74 - 87
  • [30] Evolution in the treatment of hematologic malignancies
    de Pauw, BE
    CURRENT OPINION IN ONCOLOGY, 2005, 17 (06) : 593 - 596
12345